Patents by Inventor Murray Resnick

Murray Resnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12670595
    Abstract: In some aspects, a method, a system, or a non-transitory computer-readable storage medium are described for training one or more models to predict ulcerative colitis (UC) severity based on human-interpretable image features extracted from a whole-slide image, including acts of accessing a plurality of annotated whole-slide images associated with a plurality of UC patients, wherein each of the plurality of annotated whole-slide images includes at least one annotation describing a cell-type label or a tissue-type segmentation for a portion of the whole-slide image, extracting a plurality of human-interpretable image features based on cell-type labels and tissue-type segmentations associated with the plurality of annotated whole-slide images, training a statistical model based on the plurality of human-interpretable image features to predict the UC severity for a whole-slide image, and storing the trained model on at least one storage device.
    Type: Grant
    Filed: August 19, 2024
    Date of Patent: June 30, 2026
    Assignee: PathAI, Inc.
    Inventors: Fedaa Najdawi, Kathleen Sucipto, Archit Khosla, Michael Drage, Amaro N. Taylor-Weiner, Michael C. Montalto, Murray Resnick, Maryam Pouryahya, Stephanie Hennek, Ilan N. Wapinski, Andrew H. Beck, Christina Jayson, Chintan Shah, Waleed Tahir, John Shamshoian, Michael Griffin, Lani Clinton, Zahil Shanis, Carlos Gaitán, Jin Li, George Hu, Andrew Walker, Harshith Padigela, Harsha Vardhan Pokkalla, Yibo Zhang, Emma Krause, Jimish Mehta
  • Publication number: 20260000343
    Abstract: In some aspects, the described systems and methods provide for a method for training a deep learning model to assess liver pathology, including accessing annotated liver pathology images associated with a group of patients in one or more randomized controlled clinical trials of nonalcoholic steatohepatitis therapy, each of the annotated liver pathology images including at least one annotation describing one or more tissue characteristic categories for a portion of the image, and training the deep learning model based on the annotated liver pathology images to predict the tissue characteristic categories, selected from a group comprising steatosis, lobular inflammation, hepatocyte ballooning, and fibrosis stage.
    Type: Application
    Filed: July 8, 2025
    Publication date: January 1, 2026
    Applicant: PathAI, Inc.
    Inventors: Amaro N. Taylor-Weiner, Harsha Vardhan Pokkalla, Hunter L. Elliott, Benjamin P. Glass, Ilan N. Wapinski, Aditya Khosla, Murray Resnick, Michael C. Montalto, Andrew H. Beck, Zahil Shanis, Aryan Pedawi, Quang Huy Le, Jason K. Wang, Maryam Pouryahya, Kenneth Knute Leidal, Oscar M. Carrasco-Zevallos, Dinkar Juyal, Charles Biddle-Snead, Katy Wack
  • Patent number: 12383191
    Abstract: In some aspects, the described systems and methods provide for a method for training a deep learning model to assess liver pathology, including accessing annotated liver pathology images associated with a group of patients in one or more randomized controlled clinical trials of nonalcoholic steatohepatitis therapy, each of the annotated liver pathology images including at least one annotation describing one or more tissue characteristic categories for a portion of the image, and training the deep learning model based on the annotated liver pathology images to predict the tissue characteristic categories, selected from a group comprising steatosis, lobular inflammation, hepatocyte ballooning, and fibrosis stage.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: August 12, 2025
    Assignee: PathAI, Inc.
    Inventors: Amaro N. Taylor-Weiner, Harsha Vardhan Pokkalla, Hunter L. Elliott, Benjamin P. Glass, Ilan N. Wapinski, Aditya Khosla, Murray Resnick, Michael C. Montalto, Andrew H. Beck, Zahil Shanis, Aryan Pedawi, Quang Huy Le, Jason K. Wang, Maryam Pouryahya, Kenneth Knute Leidal, Oscar M. Carrasco-Zevallos, Dinkar Juyal, Charles Biddle-Snead, Katy Wack
  • Publication number: 20220375606
    Abstract: Techniques for performing diagnostic assessments based on digital pathology data are disclosed. In one particular embodiment, the techniques may be realized as a method for performing a diagnostic assessment based on digital pathology data comprising obtaining first digital pathology data comprising intensity information, the first digital pathology data being associated with a plurality of regions of interest in a biological sample; applying first machine learning models to the first digital pathology data, the first machine learning models identifying first regions of interest among the plurality of regions of interest based on the intensity information; applying second machine learning models to the first digital pathology data, the second machine learning models identifying at least one pattern associated with at least one of the first regions of interest; generating a diagnostic assessment based on the first regions of interest and the at least one pattern.
    Type: Application
    Filed: May 18, 2022
    Publication date: November 24, 2022
    Inventors: Benjamin GLASS, Surya Teja CHAVALI, Syed Ashar JAVED, Shamira Sridharan WEAVER, Murray RESNICK, Ilan WAPINSKI, Michael MONTALTO, Andrew Hanno BECK, Aditya KHOSLA
  • Patent number: 9784743
    Abstract: The specification provides methods of determining whether a subject suffering from ER+/HER2+ breast cancer is likely to respond to adjuvant and neoadjuvant chemotherapy and methods of treating a subject suffering from ER+/HER2+ breast cancer.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: October 10, 2017
    Assignee: Rhode Island Hospital, A Lifespan-Partner
    Inventors: Alexander S. Brodsky, Yihong Wang, Murray Resnick
  • Publication number: 20160370371
    Abstract: The specification provides methods of determining whether a subject suffering from ER+/HER2+ breast cancer is likely to respond to adjuvant and neoadjuvant chemotherapy and methods of treating a subject suffering from ER+/HER2+ breast cancer.
    Type: Application
    Filed: June 20, 2016
    Publication date: December 22, 2016
    Inventors: Alexander S. Brodsky, Yihong Wang, Murray Resnick